Capital Hill Watch
Access Act of 2003 (H.R. 2427)
Thursday, July 24, 2003, the House of Representatives is expected to
consider the Pharmaceutical Market Access Act of 2003 (H.R. 2427) (To
view: Full text of legislation)
this measure, the FDA must design and implement a system to grant individuals,
pharmacists and wholesalers in America access to FDA-approved drugs
from FDA-approved facilities in industrialized nations abroad.
European Union, Australia, Canada, Iceland, Israel, Japan, Lichtenstein,
New Zealand, Norway, Switzerland, and South Africa are the only included
countries. Mexico is not included.
prescription drugs produced at home and abroad are required to use counterfeit-resistant
packaging, similar to the technology used by the U.S. Department of
the Treasury by the Pharmaceutical Market Access Act of 2003 (H.R. 2427).
allow the re-importation of prescription drugs manufactured or sold
abroad by U.S. companies would be of little benefit to American consumers. Overall prescription drug costs have undergone
a rapid rise as a result of increased utilization of prescription medications.
Also, access to important new medications in the U.S. and abroad
would be reduced by attempts to establish the same prices for drugs
in the U.S. and abroad. Furthermore, access to the most effective new
drugs are limited by price controls and other governmental restrictions
in almost every other industrialized nation.
Can You Do?
Market Access Act of 2003 (H.R. 2427).
Hill Switchboard Numbers: 202-225-3121 or 202-224-3121 (Those numbers
will direct you to the Capitol Hill operator. Ask for your representative's
To go to
your representative's website, find his E-mail or to find out who your
representatives are... http://www.house.gov/house/MemberWWW.html .
mail your U.S. House of Representative, go to http://www.house.gov/htbin/wrep_findrep.
Honorable (full name)
United States House of Representatives
Washington, DC 20515
Representative (last name):
to the American Voice Institute of Public Policy Home Page